Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Previous issues

Page Path
HOME > Browse articles > Previous issues
15 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 12(3); July 2014
Prev issue Next issue
Commentary
Crohn's Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn's Disease in Korea
Jae Hee Cheon, You Sun Kim, Byong Duk Ye, Kang Moon Lee, Young Ho Kim, Joo Sung Kim, Dong Soo Han, Won Ho Kim
Intest Res 2014;12(3):173-175.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.173
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Modern treatment of perianal fistulas following Crohn’s disease
    A.L. Bejanyan, A.A. Bumbazhai, K.N. Petrenko, A.A. Sumbaev, A.V. Matinyan, I.I. Eremin
    Regenerative biotechnologies, preventive, digital and predictive medicine.2024; 1(2): 49.     CrossRef
  • Inflammatory bowel disease in Korea: epidemiology and pathophysiology
    Jung Won Lee, Chang Soo Eun
    The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
  • Clinical Characteristics of Korean Patients with Elderly-Onset Crohn’s Disease: Results from the Prospective CONNECT Study
    You Sun Kim, Min Jeong Na, Byong Duk Ye, Jae Hee Cheon, Jong Pil Im, Joo Sung Kim
    Gut and Liver.2022; 16(6): 995.     CrossRef
  • Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study
    Seung Wook Hong, Byong Duk Ye, Jae Hee Cheon, Ji Hyun Lee, Ja Seol Koo, Byung Ik Jang, Kang-Moon Lee, You Sun Kim, Tae Oh Kim, Jong Pil Im, Geun Am Song, Sung-Ae Jung, Hyun Soo Kim, Dong Il Park, Hyun-Soo Kim, Kyu Chan Huh, Young-Ho Kim, Jae Myung Cha, Ge
    Gut and Liver.2022; 16(6): 907.     CrossRef
  • Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View
    Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu
    Annals of Coloproctology.2021; 37(1): 5.     CrossRef
  • Epidemiology and diagnosis of inflammatory bowel diseases
    Kang-Moon Lee
    Journal of the Korean Medical Association.2021; 64(9): 579.     CrossRef
  • Clinical Features of Intra-Abdominal Abscess and Intestinal Free-Wall Perforation in Korean Patients with Crohn’s Disease: Results from the CONNECT Study
    Seok-Hoo Jeong, Ja Sung Choi, Jin Woo Kim, Hee Man Kim, Hyun-Soo Kim, Jong Pil Im, Joo Sung Kim, You Sun Kim, Jae Hee Cheon, Won Ho Kim, Byong Duk Ye, Young-Ho Kim, Dong Soo Han
    Journal of Clinical Medicine.2020; 10(1): 116.     CrossRef
  • Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East
    Masoud M Malekzadeh, Alireza Sima, Sudabeh Alatab, Anahita Sadeghi, Nasser Ebrahimi Daryani, Payman Adibi, Iradj Maleki, Hassan Vossoughinia, Hafez Fakheri, Abbas Yazdanbod, Seyed Alireza Taghavi, Rahim Aghazadeh, Mohammad Hassan Somi, Kazem Zendedel, Hom
    Intestinal Research.2019; 17(3): 330.     CrossRef
  • Postoperative course of Crohn disease according to timing of bowel resection
    Ji Min Lee, Kang-Moon Lee, Joo Sung Kim, You Sun Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, Dong Soo Han, Chang Kyun Lee, Hyun-Ju Park
    Medicine.2018; 97(16): e0459.     CrossRef
  • Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
    Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
    Gut and Liver.2018; 12(5): 544.     CrossRef
  • Second Korean Guidelines for the Management of Crohn's Disease
    Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
    The Korean Journal of Gastroenterology.2017; 69(1): 29.     CrossRef
  • Second Korean guidelines for the management of Crohn's disease
    Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
    Intestinal Research.2017; 15(1): 38.     CrossRef
  • Serum Adipocytokine Levels as Surrogate Markers for Disease Activity of Crohn’s Disease
    Su Hwan Kim, Seung Hyeon Jang, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, You Sun Kim, Dong Soo Han, Joo Sung Kim
    The American Journal of the Medical Sciences.2017; 353(5): 439.     CrossRef
  • A coding variant inFTOconfers susceptibility to thiopurine-induced leukopenia in East Asian patients with IBD
    Han Sang Kim, Jae Hee Cheon, Eun Suk Jung, Joonhee Park, Sowon Aum, Soo Jung Park, Sungho Eun, Jinu Lee, Ulrich Rüther, Giles S H Yeo, Marcella Ma, Kyong Soo Park, Takeo Naito, Yoichi Kakuta, Ji Hyun Lee, Won Ho Kim, Min Goo Lee
    Gut.2017; 66(11): 1926.     CrossRef
  • Development of a Novel Predictive Model for the Clinical Course of Crohnʼs Disease
    Yehyun Park, Jae Hee Cheon, Yi Lang Park, Byong Duk Ye, You Sun Kim, Dong Soo Han, Joo Sung Kim, Sung Noh Hong, Young Ho Kim, Seong Ran Jeon, Won Ho Kim
    Inflammatory Bowel Diseases.2017; 23(7): 1071.     CrossRef
  • Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study
    Sung Wook Hwang, Jee Hyun Kim, Jong Pil Im, Byong Duk Ye, Hoon Sup Koo, Kyu Chan Huh, Jae Hee Cheon, You Sun Kim, Young Ho Kim, Dong Soo Han, Won Ho Kim, Joo Sung Kim
    Journal of Gastroenterology and Hepatology.2017; 32(10): 1716.     CrossRef
  • Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study
    Bun Kim, Jae Hee Cheon, Hyun Jin Moon, Yi Rang Park, Byong Duk Ye, Suk‐Kyun Yang, Geom Seog Seo, Byung Ik Jang, You Sun Kim, Joo Sung Kim, Dong Soo Han, Young‐Ho Kim, Won Ho Kim
    Journal of Gastroenterology and Hepatology.2016; 31(1): 126.     CrossRef
  • Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants
    Sung Noh Hong, Changho Park, Soo Jung Park, Chang Kyun Lee, Byong Duk Ye, You Sun Kim, Seungbok Lee, Jeesoo Chae, Jong-Il Kim, Young-Ho Kim
    Gut.2016; 65(5): 788.     CrossRef
  • Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
    Jee Hye Kwon, Jong Pil Im, Byong Duk Ye, Jae Hee Cheon, Hyun Joo Jang, Kang Moon Lee, You Sun Kim, Sang Wook Kim, Young Ho Kim, Geun Am Song, Dong Soo Han, Won Ho Kim, Joo Sung Kim
    Gut and Liver.2016; 10(4): 595.     CrossRef
  • The clinical characteristics of patients with free perforation in Korean Crohn’s disease: results from the CONNECT study
    Young Seok Doh, You Sun Kim, Song I Bae, Jong Pil Im, Jae Hee Cheon, Byong Duk Ye, Ji Won Kim, Young Sook Park, Ji Hyun Lee, Young-Ho Kim, Joo Sung Kim, Dong Soo Han, Won Ho Kim
    BMC Gastroenterology.2015;[Epub]     CrossRef
  • Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn’s Disease Patients: Results from the CONNECT Study
    Chang Mo Moon, Sung-Ae Jung, Seong-Eun Kim, Hyun Joo Song, Yunho Jung, Byong Duk Ye, Jae Hee Cheon, You Sun Kim, Young-Ho Kim, Joo Sung Kim, Dong Soo Han, Mathias Chamaillard
    PLOS ONE.2015; 10(12): e0144390.     CrossRef
  • Long-term Clinical Outcomes of Urban Versus Rural Environment in Korean Patients with Crohn's Disease: Results from the CONNECT Study
    Y. S. Jung, D. I. Park, B. D. Ye, J. H. Cheon, Y. S. Kim, Y. H. Kim, J. S. Kim, H. S. Chae, G. H. Baik, D. S. Han
    Journal of Crohn's and Colitis.2015; 9(3): 246.     CrossRef
  • Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
    Jung Won Lee, Jong Pil Im, Jae Hee Cheon, You Sun Kim, Joo Sung Kim, Dong Soo Han
    Intestinal Research.2015; 13(3): 213.     CrossRef
  • Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center Study
    Sinyoung Park, Yang Hee Noh, Sun Young Rha, Won Ho Kim, Jae Hee Cheon
    Intestinal Research.2015; 13(3): 274.     CrossRef
  • Crohn's disease in Korea: past, present, and future
    Kang-Moon Lee, Ji Min Lee
    The Korean Journal of Internal Medicine.2014; 29(5): 558.     CrossRef
  • 6,225 View
  • 73 Download
  • 23 Web of Science
  • 25 Crossref
Close layer
Editorial
Close layer
Reviews
Current Status and Prospects of Intestinal Microbiome Studies
Dong Soo Han
Intest Res 2014;12(3):178-183.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.178
AbstractAbstract PDFPubReaderePub

The incidence and prevalence of inflammatory bowel disease (IBD) in Asia has witnessed a rapid increase within a few decades. The genetic susceptibility and epidemiologic backgrounds in the Asian population have been found to be different from that of Western populations. There is an extensive crosstalk between gut microbiota and human hosts, with evidence of reciprocal interactions. It is well known that gut microbiota can affect the host immune system and in turn, host genetic backgrounds can affect gut microbiota reciprocally. Evidences have implicated gut microbes in the development of IBD, but no causative microorganisms have been identified. Recent advances in sequencing technology and computational analysis have now made identification of complex gut microbiomes accessible. Further research targeting gut microbiota could help in identifying biomarkers to predict clinical response, and therapeutic modalities that might affect their resilience.

Citations

Citations to this article as recorded by  
  • Long‐term effects of fecal microbiota transplantation on gut microbiota after Helicobacter pylori eradication with bismuth quadruple therapy: A randomized controlled trial
    Jing‐Tao Zhao, Yi Zhang, Xing‐Wei Wang, Pei‐Ying Zou, Zhe Zhao, Hao Mei, Yu‐Xiang Liu, Na‐Yun Su, Yang‐Jie Zhu, Bin Wang, Yan‐Ling Wei, Dong‐Feng Chen, Chun‐Hui Lan
    Helicobacter.2024;[Epub]     CrossRef
  • A COMBINATION REVIEW ON EFFECT OF CITRUS JUICE AND METRONIDAZOLE IN INFLAMMATORY BOWEL DISEASE
    Deeksha, Shalini Saini, Meenakshi Bhatt
    International Journal of Research -GRANTHAALAYAH.2023;[Epub]     CrossRef
  • Dysbiosis, Host Metabolism, and Non-communicable Diseases: Trialogue in the Inborn Errors of Metabolism
    Chiara Montanari, Sara Parolisi, Elisa Borghi, Lorenza Putignani, Giulia Bassanini, Juri Zuvadelli, Cristina Bonfanti, Albina Tummolo, Carlo Dionisi Vici, Giacomo Biasucci, Alberto Burlina, Maria Teresa Carbone, Elvira Verduci
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis
    Katsuyoshi Matsuoka, Yukari Uemura, Takanori Kanai, Reiko Kunisaki, Yasuo Suzuki, Kaoru Yokoyama, Naoki Yoshimura, Toshifumi Hibi
    Digestive Diseases and Sciences.2018; 63(7): 1910.     CrossRef
  • Effects of the Administration of Probiotics on Fecal Microbiota Diversity and Composition in Healthy Individuals
    Choong-Kyun Noh, Bong Sun Kim, Gana Hong, Jae Youn Cheong, Kwang Jae Lee
    Journal of Neurogastroenterology and Motility.2018; 24(3): 452.     CrossRef
  • Chlorogenic acid suppresses lipopolysaccharide-induced nitric oxide and interleukin-1β expression by inhibiting JAK2/STAT3 activation in RAW264.7 cells
    Sang-Hun Kim, Sun-Young Park, Young-Lan Park, Dae-Seong Myung, Jong-Sun Rew, Young-Eun Joo
    Molecular Medicine Reports.2017; 16(6): 9224.     CrossRef
  • Metronidazole-induced encephalopathy in a patient with Crohn's disease
    Jihye Kim, Jaeyoung Chun, Jae Yong Park, Seung Wook Hong, Joo Young Lee, Jin Woo Kang, Seongjun Hwang, Sang-Bae Ko, Jong Pil Im, Joo Sung Kim
    Intestinal Research.2017; 15(1): 124.     CrossRef
  • The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review
    Rosario Lucas López, María José Grande Burgos, Antonio Gálvez, Rubén Pérez Pulido
    APMIS.2017; 125(1): 3.     CrossRef
  • Can Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-inflammatory Drug-induced Small Bowel Injury?
    Seong Ran Jeon
    The Korean Journal of Gastroenterology.2016; 68(2): 123.     CrossRef
  • The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial
    Bumjo Oh, Bong‐Soo Kim, Ji Won Kim, Jong Seung Kim, Seong‐Joon Koh, Byeong Gwan Kim, Kook Lae Lee, Jongsik Chun
    Helicobacter.2016; 21(3): 165.     CrossRef
  • Does the intestinal microbial community of Korean Crohn’s disease patients differ from that of western patients?
    Chang Soo Eun, Min-Jung Kwak, Dong Soo Han, A. Reum Lee, Dong Il Park, Suk-Kyun Yang, Yong Seok Kim, Jihyun F. Kim
    BMC Gastroenterology.2016;[Epub]     CrossRef
  • Phenylketonuria and Gut Microbiota: A Controlled Study Based on Next-Generation Sequencing
    Felipe Pinheiro de Oliveira, Roberta Hack Mendes, Priscila Thiago Dobbler, Volker Mai, Victor Salter Pylro, Sheldon G Waugh, Filippo Vairo, Lilia Farret Refosco, Luiz Fernando Würdig Roesch, Ida Vanessa Doederlein Schwartz, Brenda A Wilson
    PLOS ONE.2016; 11(6): e0157513.     CrossRef
  • Metabolome of human gut microbiome is predictive of host dysbiosis
    Peter E. Larsen, Yang Dai
    GigaScience.2015;[Epub]     CrossRef
  • Alteration of Fecal Microbiota in Patients With Postinfectious Irritable Bowel Syndrome (Gut 2014;63:1737-1745)
    Young-Eun Joo
    Journal of Neurogastroenterology and Motility.2015; 21(1): 135.     CrossRef
  • Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?
    Chang Soo Eun, Dong Soo Han
    Gut and Liver.2015;[Epub]     CrossRef
  • Cross-Regulation of Innate and Adaptive Immunity: A New Perspective for the Pathogenesis of Inflammatory Bowel Disease
    Da Yeon Oh, Seong-Joon Koh
    Gut and Liver.2015;[Epub]     CrossRef
  • 6,037 View
  • 58 Download
  • 15 Web of Science
  • 16 Crossref
Close layer
Clinical Application of Genetics in Management of Colorectal Cancer
Eun Ran Kim, Young-Ho Kim
Intest Res 2014;12(3):184-193.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.184
AbstractAbstract PDFPubReaderePub

The extensive study of genetic alterations in colorectal cancer (CRC) has led to molecular diagnostics playing an increasingly important role in CRC diagnosis and treatment. Currently, it is believed that CRC is a consequence of the accumulation of both genetic and epigenetic genomic alterations. It is known that there are at least 3 major pathways that lead to colorectal carcinogenesis: (1) the chromosomal instability pathway, (2) the microsatellite instability pathway, and (3) the cytosine-phospho-guanine island methylator phenotype pathway. With recent advances in CRC genetics, the identification of specific molecular alterations responsible for CRC pathogenesis has directly influences clinical care. Patients at high risk for developing CRC can be identified by genetic testing for specific molecular alterations, and the use of molecular biomarkers for predictive and prognostic purposes is also increasing. This is clearly supported by the recent advances in genetic testing for CRC whereby specific molecular alterations are identified for the purpose of guiding treatment with targeting therapies such as anti-endothelial growth factor receptor monoclonal antibodies.

Citations

Citations to this article as recorded by  
  • Randomized non-inferiority single-center prospective trial of malignant colonic obstruction therapy with Self-expandable metal stent (SEMS) endoscopic placement or stoma formation
    I.E. Gorovaia, P.V. Tsarkov, P.V. Pavlov, I.A. Tulina, V.I. Zhurkovskiy
    Endoscopic Surgery.2024; 30(2): 5.     CrossRef
  • Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002–09 and 2010–17
    Shirley H. F. Lee, Hanif Abdul Rahman, Nadiah Abidin, Sok King Ong, Elvynna Leong, Lin Naing
    BMC Cancer.2021;[Epub]     CrossRef
  • Three-year colonoscopy surveillance after polypectomy in Korea: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter prospective study
    Won Seok Choi, Dong Soo Han, Chang Soo Eun, Dong Il Park, Jeong-Sik Byeon, Dong-Hoon Yang, Sung-Ae Jung, Sang Kil Lee, Sung Pil Hong, Cheol Hee Park, Suck-Ho Lee, Jeong-Seon Ji, Sung Jae Shin, Bora Keum, Hyun Soo Kim, Jung Hye Choi, Sin-Ho Jung
    Intestinal Research.2018; 16(1): 126.     CrossRef
  • Genetic and epigenetic alterations of colorectal cancer
    Sung Noh Hong
    Intestinal Research.2018; 16(3): 327.     CrossRef
  • Hepatitis B Virus Infection Is Independently Associated With Advanced Colorectal Adenoma
    Su Hwan Kim, Ji Won Kim, Kook Lae Lee, Seohui Lee, Seong-Joon Koh, Ji Bong Jeong, Byeong Gwan Kim
    The American Journal of the Medical Sciences.2018; 356(2): 141.     CrossRef
  • Is methylation analysis ofSFRP2,TFPI2,NDRG4, andBMP3promoters suitable for colorectal cancer screening in the Korean population?
    Soo-Kyung Park, Hae Lim Baek, Junghee Yu, Ji Yeon Kim, Hyo-Joon Yang, Yoon Suk Jung, Kyu Yong Choi, Hungdai Kim, Hyung Ook Kim, Kyung Uk Jeong, Ho-Kyung Chun, Kyungeun Kim, Dong Il Park
    Intestinal Research.2017; 15(4): 495.     CrossRef
  • Malformin A1 treatment alters invasive and oncogenic phenotypes of human colorectal cancer cells through stimulation of the p38 signaling pathway
    Sun-Young Park, Hyung-Hoon Oh, Young-Lan Park, Hyung-Min Yu, Dae-Seong Myung, Sung-Bum Cho, Wan-Sik Lee, Daeho Park, Young-Eun Joo
    International Journal of Oncology.2017; 51(3): 959.     CrossRef
  • Expression of inositol-requiring enzyme 1β is downregulated in colorectal cancer
    Yalin Jiang, Yunfeng Zhou, Yufeng Zheng, Hong Guo, Lei Gao, Pan Chen, Dandan Feng, Ran Qi, Xiaozhen Li, Yongchao Chang, Fong-Fong Chu, Qiang Gao
    Oncology Letters.2017; 13(3): 1109.     CrossRef
  • Obesity-related parameters and colorectal adenoma development
    Tae Jun Kim, Jee Eun Kim, Yoon-Ho Choi, Sung Noh Hong, Young-Ho Kim, Dong Kyung Chang, Poong-Lyul Rhee, Min-Ji Kim, Sin-Ho Jung, Hee Jung Son
    Journal of Gastroenterology.2017; 52(12): 1221.     CrossRef
  • The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance
    Abdo Alnabulsi, Rebecca Swan, Beatriz Cash, Ayham Alnabulsi, Graeme I Murray
    British Journal of Cancer.2017; 116(12): 1612.     CrossRef
  • Myofibroblasts of the muscle layer stimulate the malignant potential of colorectal cancer
    Masafumi Takatsuna, Satoko Morohashi, Tadashi Yoshizawa, Hideaki Hirai, Toshihiro Haga, Rie Ota, Yunyan Wu, Hajime Morohashi, Kenichi Hakamada, Shuji Terai, Hiroshi Kijima
    Oncology Reports.2016; 36(3): 1251.     CrossRef
  • Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia
    Nam Hee Kim, Min-Jung Kwon, Hyun-young Kim, Taeheon Lee, Seok Hyeon Jeong, Dong Il Park, Kyuyong Choi, Yoon Suk Jung
    Digestive and Liver Disease.2016; 48(6): 667.     CrossRef
  • Statin use and the risk of colorectal adenoma: A meta‐analysis
    Yoon Suk Jung, Chan Hyuk Park, Chang Soo Eun, Dong Il Park, Dong Soo Han
    Journal of Gastroenterology and Hepatology.2016; 31(11): 1823.     CrossRef
  • Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer
    NURI KIM, SUNG-BUM CHO, YOUNG-LAN PARK, SUN-YOUNG PARK, EUN MYUNG, SEUNG-HUN KIM, HYUNG-MIN YU, YOUNG-AE SON, DAE-SEONG MYUNG, WAN-SIK LEE, YOUNG-EUN JOO
    Oncology Reports.2016; 35(6): 3331.     CrossRef
  • Field Cancerization in Sporadic Colon Cancer
    Soo-Kyung Park, Chang Seok Song, Hyo-Joon Yang, Yoon Suk Jung, Kyu Yong Choi, Dong Hoe Koo, Kyung Eun Kim, Kyung Uk Jeong, Hyung Ook Kim, Hungdai Kim, Ho-Kyung Chun, Dong Il Park
    Gut and Liver.2016; 10(5): 773.     CrossRef
  • Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer
    HYUNG-HOON OH, KANG-JIN PARK, NURI KIM, SUN-YOUNG PARK, YOUNG-LAN PARK, CHAN-YOUNG OAK, DAE-SEONG MYUNG, SUNG-BUM CHO, WAN-SIK LEE, KYUNG-KEUN KIM, YOUNG-EUN JOO
    Oncology Reports.2016; 35(1): 253.     CrossRef
  • Risk Factors Such as Male Sex, Smoking, Metabolic Syndrome, Obesity, and Fatty Liver Do Not Justify Screening Colonoscopies Before Age 45
    Yoon Suk Jung, Kyung Eun Yun, Yoosoo Chang, Seungho Ryu, Dong Il Park
    Digestive Diseases and Sciences.2016; 61(4): 1021.     CrossRef
  • Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?
    Nam Hee Kim, Hyo-Joon Yang, Soo-Kyung Park, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Digestive Diseases and Sciences.2016; 61(9): 2685.     CrossRef
  • Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients
    Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim
    Medicine.2016; 95(19): e3641.     CrossRef
  • Does Stenting as a Bridge to Surgery in Left-Sided Colorectal Cancer Obstruction Really Worsen Oncological Outcomes?
    Min Seob Kwak, Wan Soo Kim, Jeong-Mi Lee, Dong-Hoon Yang, Yong Sik Yoon, Chang Sik Yu, Jin Cheon Kim, Jeong-Sik Byeon
    Diseases of the Colon & Rectum.2016; 59(8): 725.     CrossRef
  • Risk of Advanced Colorectal Neoplasia According to the Number of High-Risk Findings at Index Colonoscopy: A Korean Association for the Study of Intestinal Disease (KASID) Study
    Yoon Suk Jung, Dong Il Park, Won Hee Kim, Chang Soo Eun, Soo-Kyung Park, Bong Min Ko, Geom Seog Seo, Jae Myung Cha, Jae Jun Park, Kyeong Ok Kim, Chang Mo Moon, Yunho Jung, Eun Soo Kim, Seong Ran Jeon, Chang Kyun Lee
    Digestive Diseases and Sciences.2016; 61(6): 1661.     CrossRef
  • Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps
    Taeyoung Lee, Kyung Eun Yun, Yoosoo Chang, Seungho Ryu, Dong Il Park, Kyuyong Choi, Yoon Suk Jung
    Digestive Diseases and Sciences.2016; 61(1): 317.     CrossRef
  • Associations between amount of smoking and alcohol intake and risk of colorectal neoplasm
    Yoon Suk Jung, Hwanseok Jung, Kyung Eun Yun, Seungho Ryu, Yoosoo Chang, Dong Il Park, Kyuyong Choi
    Journal of Gastroenterology and Hepatology.2016; 31(4): 788.     CrossRef
  • Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer
    Young-Lan Park, Sun-Young Park, Seung-Hyun Lee, Rul-Bin Kim, Joong-Keun Kim, Sung-Yoon Rew, Dae-Seong Myung, Sung-Bum Cho, Wan-Sik Lee, Hyun-Soo Kim, Young-Eun Joo
    Oncotarget.2016; 7(44): 72229.     CrossRef
  • Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer
    Rebecca Swan, Abdo Alnabulsi, Beatriz Cash, Ayham Alnabulsi, Graeme I. Murray
    Oncotarget.2016; 7(29): 46509.     CrossRef
  • Associations Between Parameters of Glucose and Lipid Metabolism and Risk of Colorectal Neoplasm
    Yoon Suk Jung, Seungho Ryu, Yoosoo Chang, Kyung Eun Yun, Jung Ho Park, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyuyong Choi, Dong Il Park
    Digestive Diseases and Sciences.2015; 60(10): 2996.     CrossRef
  • Clinical Features and Prognosis of Resectable Primary Colorectal Signet-Ring Cell Carcinoma
    Ho-Su Lee, Jae Seung Soh, Seohyun Lee, Jung Ho Bae, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sun A Kim, Young Soo Park, Seok-Byung Lim, Jin Cheon Kim, Chang Sik Yu, Dong-Hoon Yang
    Intestinal Research.2015; 13(4): 332.     CrossRef
  • Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer
    David M. Zocche, Carolina Ramirez, Fernando M. Fontao, Lucas D. Costa, María A. Redal
    Frontiers in Genetics.2015;[Epub]     CrossRef
  • Long non-coding RNA LINC01296 is a potential prognostic biomarker in patients with colorectal cancer
    Jia-jun Qiu, Jing-bin Yan
    Tumor Biology.2015; 36(9): 7175.     CrossRef
  • Prognostic Significance of CpG Island Methylator Phenotype in Colorectal Cancer
    Young-Eun Joo
    Gut and Liver.2015; 9(2): 139.     CrossRef
  • Serrated Polyps and Their Alternative Pathway to the Colorectal Cancer: A Systematic Review
    Łukasz Szylberg, Marlena Janiczek, Aneta Popiel, Andrzej Marszałek
    Gastroenterology Research and Practice.2015; 2015: 1.     CrossRef
  • Correlational research of Golgi phosphorylation protein 3 expression in colorectal cancer
    Yan-Ta Guo
    World Journal of Gastroenterology.2015; 21(48): 13473.     CrossRef
  • Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
    Dt R. Howarth, Sharon S. Lum, Pamela Esquivel, Carlos A. Garberoglio, Maheswari Senthil, Naveenraj L. Solomon
    The American Surgeon.2015; 81(10): 941.     CrossRef
  • Glycoprotein A33 deficiency: a new model of impaired intestinal epithelial barrier function and inflammatory disease
    Benjamin B. Williams, Niall C. Tebbutt, Michael Buchert, Tracy L. Putoczki, Karen Doggett, Shisan Bao, Cameron N. Johnstone, Frederick Masson, Frederic Hollande, Antony W. Burgess, Andrew M. Scott, Matthias Ernst, Joan K. Heath
    Disease Models & Mechanisms.2015;[Epub]     CrossRef
  • 7,036 View
  • 37 Download
  • 40 Web of Science
  • 34 Crossref
Close layer
Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future
Wong Zhiqin, Shanthi Palaniappan, Raja Affendi Raja Ali
Intest Res 2014;12(3):194-204.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.194
AbstractAbstract PDFPubReaderePub

Patients with inflammatory bowel disease (IBD) are at an increased risk of developing colorectal cancer (CRC), and key contributing factors include chronic colonic inflammation and the extent and duration of disease. This increase in risk is more likely to result from chronic inflammation of the colonic mucosa than from any clearly defined genetic predisposition. However, globally, the true magnitude of this risk is debatable, since results from different studies are heterogeneous in terms of geographical and methodological variables. The prevalence of IBD-related CRC in the Asia-Pacific region ranges from 0.3% to 1.8% and a recent study found that the cumulative incidence of IBD-related CRC is comparable to that in Western countries. However, the CRC mortality rate in the Asia-Pacific region is on the rise compared with that in Western countries, and a few Asian countries show particularly rapid upward trends in CRC incidence. Although our understanding of the molecular and clinical basis for IBD-related CRC has improved substantially, our means of prevention, endoscopic surveillance, chemoprevention, and prophylactic surgery remain modest at best. Furthermore, published data on IBD-related CRC in the Asia-Pacific region is lacking, and this review addresses many aspects including epidemiology, natural history, etiopathogenesis, morphology, and biological behaviors of IBD-related CRC and sporadic CRC in the Asia-Pacific region. In this review, we will also discuss the risk factors for CRC in IBD patients, endoscopic technology screening, and surveillance programs and management strategies for IBD-related CRC.

Citations

Citations to this article as recorded by  
  • Role of Healthy Lifestyle and Diet Quality in the Development of Colorectal Cancer in the Adult Population in the Kurdistan Region: A Case-Control Study
    Ayid M Qasim, Sardar H Arif
    Cureus.2024;[Epub]     CrossRef
  • Megastigmane sesquiterpenoids from Saussurea medusa and their anti-inflammatory activities
    Jing-Ya Cao, Qi Dong, Zhi-Yao Wang, Ye Zhao, Yu Ren, Li-Juan Mei, Yan-duo Tao, Rui-Tao Yu
    Natural Product Research.2023; 37(18): 3074.     CrossRef
  • Influence of neo-adjuvant radiotherapy on the intestinal microbiota of rectal cancer patients
    Siyang Xu, Qimei Lv, Ning Zou, Yuling Zhang, Jiucheng Zhang, Qing Tang, Shan-Ho Chou, Li Lu, Jin He
    Journal of Cancer Research and Clinical Oncology.2023; 149(9): 6085.     CrossRef
  • Roles of phosphatidylinositol-3-kinases signaling pathway in inflammation-related cancer: Impact of rs10889677 variant and buparlisib in colitis-associated cancer
    Nurul Nadirah Razali, Raja Affendi Raja Ali, Khairul Najmi Muhammad Nawawi, Azyani Yahaya, Norshafila Diana Mohd Rathi, Norfilza Mohd Mokhtar
    World Journal of Gastroenterology.2023; 29(40): 5543.     CrossRef
  • Colitis-Associated Colorectal Cancer in Patients with Inflammatory Bowel Diseases in a Tertiary Referral Center: A Propensity Score Matching Analysis
    Kasper Maryńczak, Jakub Włodarczyk, Zofia Sabatowska, Adam Dziki, Łukasz Dziki, Marcin Włodarczyk
    Journal of Clinical Medicine.2022; 11(3): 866.     CrossRef
  • Arylnaphthalide lignans from Saussurea medusa and their anti-inflammatory activities
    Jing-Ya Cao, Qi Dong, Zhi-Yao Wang, Ye Zhao, Yu Ren, Chang Liu, Jun Dang, Rui-Tao Yu, Yan-Duo Tao
    Arabian Journal of Chemistry.2022; 15(10): 104155.     CrossRef
  • Targeted Sequencing of Cytokine-Induced PI3K-Related Genes in Ulcerative Colitis, Colorectal Cancer and Colitis-Associated Cancer
    Nurul Nadirah Razali, Raja Affendi Raja Ali, Khairul Najmi Muhammad Nawawi, Azyani Yahaya, Norfilza M. Mokhtar
    International Journal of Molecular Sciences.2022; 23(19): 11472.     CrossRef
  • Recent Advance in the Management of Dysplasia in the Ulcerative Colitis
    Dong-Hoon Yang
    Journal of Digestive Cancer Reports.2021; 9(2): 50.     CrossRef
  • Ethanol Extract of Pomegranate (Punica granatum) Peel in Increasing the Expression of Caspase-3 in DSS-Induced Mice
    Kusmardi Kusmardi, Lyanna Azzahra Baihaqi, Ari Estuningtyas, Nurhuda Sahar, Hadi Sunaryo, Aryo Tedjo, Istvan Boldogh
    International Journal of Inflammation.2021; 2021: 1.     CrossRef
  • Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer
    Siyang Xu, Wen Yin, Yuling Zhang, Qimei Lv, Yijun Yang, Jin He
    Cancers.2020; 12(2): 372.     CrossRef
  • Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways
    Mohammad Hossein Pourhanifeh, Saeed Mehrzadi, Mahboobeh Kamali, Azam Hosseinzadeh
    European Journal of Pharmacology.2020; 886: 173471.     CrossRef
  • Depression, Anxiety, Related Risk Factors and Cognitive Distortion in Korean Patients with Inflammatory Bowel Disease
    Jun Ho Song, Jong Woo Kim, Chi Hyuk Oh, Hyo Jong Kim, Chang Kyun Lee, Won Sub Kang
    Psychiatry Investigation.2020; 17(11): 1126.     CrossRef
  • Tauroursodeoxycholic acid attenuates colitis‐associated colon cancer by inhibiting nuclear factor kappaB signaling
    Young Hoon Kim, Jee Hyun Kim, Byeong Gwan Kim, Kook Lae Lee, Ji Won Kim, Seong‐Joon Koh
    Journal of Gastroenterology and Hepatology.2019; 34(3): 544.     CrossRef
  • Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study
    Xian-Rui Wu, Xiao-Bin Zheng, Yan Huang, Qian Cao, Hong-Jie Zhang, Ying-Lei Miao, Kai-Fang Zou, Min Chen, Fa-Ming Zhang, Qiao Mei, David Gonzalo, Daniela Allende, Pin-Jin Hu, Bo Shen, Xiu-Li Liu, Ping Lan
    Gastroenterology Report.2019; 7(1): 67.     CrossRef
  • Endoscopic Submucosal Dissection for Colitis-Associated Dysplasia
    Dong-Hoon Yang, Imelda Rey
    Clinical Endoscopy.2019; 52(2): 120.     CrossRef
  • A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia
    Norfilza Mohd Mokhtar, Khairul Najmi Muhammad Nawawi, Jaarvis Verasingam, Wong Zhiqin, Ismail Sagap, Zairul Azwan Mohd Azman, Luqman Mazlan, Hamzaini Abdul Hamid, Nur Yazmin Yaacob, Isa Mohamed Rose, Eden Low Ngah Den, Mah Suit Wan, Raja Affendi Raja Ali
    BMC Public Health.2019;[Epub]     CrossRef
  • Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer
    Bao-Xinzi Liu, Guan-Jiang Huang, Hai-Bo Cheng
    Journal of Computational Biology.2019; 26(11): 1262.     CrossRef
  • Organometallic Compounds and Metal Complexes in Current and Future Treatments of Inflammatory Bowel Disease and Colorectal Cancer—a Critical Review
    Adrian Szczepaniak, Jakub Fichna
    Biomolecules.2019; 9(9): 398.     CrossRef
  • Sexual dimorphism in the incidence of human cancers
    Daoshan Zheng, Justyna Trynda, Cecilia Williams, Jeremy A. Vold, Justin H. Nguyen, Denise M. Harnois, Sanjay P. Bagaria, Sarah A. McLaughlin, Zhaoyu Li
    BMC Cancer.2019;[Epub]     CrossRef
  • Similarities and differences in clinical and pathologic features of inflammatory bowel disease-associated colorectal cancer in China and Canada
    Ji Li, Wei-Xun Zhou, Shuang Liu, Wei-Yang Zheng, Ya-Nan Wang, Jing-Nan Li, Jose Gp Ferraz, Jia-Ming Qian, Xian-Yong Gui
    Chinese Medical Journal.2019; 132(22): 2664.     CrossRef
  • The Natural History of IBD: Lessons Learned
    Petra Weimers, Pia Munkholm
    Current Treatment Options in Gastroenterology.2018; 16(1): 101.     CrossRef
  • Pathologic features of colorectal carcinomas associated with Crohn’s disease in Korean population
    Jiyoon Kim, Ho-Su Lee, Sang Hyoung Park, Suk-Kyun Yang, Byong Duk Ye, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Yong Sik Yoon, Chang Sik Yu, Jihun Kim
    Pathology - Research and Practice.2017; 213(3): 250.     CrossRef
  • Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease
    Jee Hyun Kim, Ji Won Kim
    Korean Journal of Gastroenterology.2017; 70(4): 162.     CrossRef
  • Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease
    Yoo Min Han, Hyuk Yoon, Soo Lim, Mi-Kyung Sung, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim
    Gut and Liver.2017; 11(3): 363.     CrossRef
  • Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted Protein-2 (CCSP-2)
    Jaeil Kim, Eun-ju Do, Helen Moinova, Sang Mun Bae, Ja Young Kang, Seung-Mo Hong, Stephen P. Fink, Jinmyoung Joo, Young-Ah Suh, Se Jin Jang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Jaewon Choe, Suk-Kyun Yang, Sanfo
    Neoplasia.2017; 19(10): 805.     CrossRef
  • Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development
    Mingsong Kang, Alberto Martin
    Seminars in Immunology.2017; 32: 3.     CrossRef
  • Effect of luteolin on inflammatory responses in RAW264.7 macrophages activated with LPS and IFN-γ
    Shuxia Wang, Meng Cao, Shuhang Xu, Jiaming Zhang, Zhiguo Wang, Xiaodong Mao, Xiaoming Yao, Chao Liu
    Journal of Functional Foods.2017; 32: 123.     CrossRef
  • The role of vitamin D in reducing gastrointestinal disease risk and assessment of individual dietary intake needs: Focus on genetic and genomic technologies
    Lynnette R. Ferguson, Bobbi Laing, Gareth Marlow, Karen Bishop
    Molecular Nutrition & Food Research.2016; 60(1): 119.     CrossRef
  • Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study—CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I
    Takuya Yoshino, Hiroshi Nakase, Tomohisa Takagi, Shigeki Bamba, Yusuke Okuyama, Takuji Kawamura, Teruki Oki, Hirozumi Obata, Chiharu Kawanami, Shinji Katsushima, Toshihiro Kusaka, Tomoyuki Tsujikawa, Yuji Naito, Akira Andoh, Takafumi Kogawa
    BMJ Open Gastroenterology.2016; 3(1): e000122.     CrossRef
  • Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease
    Min Chul Kim, Yoon Suk Jung, Young Seok Song, Jung In Lee, Jung Ho Park, Chong Il Sohn, Kyu Yong Choi, Dong Il Park
    Gut and Liver.2016;[Epub]     CrossRef
  • The continuing uncertainty about cancer risk in inflammatory bowel disease
    Hans-Olov Adami, Michael Bretthauer, Louise Emilsson, Miguel A Hernán, Mette Kalager, Jonas F Ludvigsson, Anders Ekbom
    Gut.2016; 65(6): 889.     CrossRef
  • Paf15 expression correlates with rectal cancer prognosis, cell proliferation and radiation response
    Rong Yan, Kun Zhu, Chengxue Dang, Ke Lan, Haonan Wang, Dawei Yuan, Wei Chen, Stephen J. Meltzer, Kang Li
    Oncotarget.2016; 7(25): 38750.     CrossRef
  • Long-term Clinical Outcomes of Urban Versus Rural Environment in Korean Patients with Crohn's Disease: Results from the CONNECT Study
    Y. S. Jung, D. I. Park, B. D. Ye, J. H. Cheon, Y. S. Kim, Y. H. Kim, J. S. Kim, H. S. Chae, G. H. Baik, D. S. Han
    Journal of Crohn's and Colitis.2015; 9(3): 246.     CrossRef
  • The changing epidemiology of Asian digestive cancers: From etiologies and incidences to preventive strategies
    Chun-Ying Wu, Jaw-Town Lin
    Best Practice & Research Clinical Gastroenterology.2015; 29(6): 843.     CrossRef
  • IVSE, isolated from Inula japonica,suppresses LPS-induced NO production via NF-κB and MAPK inactivation in RAW264.7 cells
    Xi Chen, Sheng-An Tang, Eunkyung Lee, Yuling Qiu, Ran Wang, Hong-Quan Duan, Shingo Dan, Meihua Jin, Dexin Kong
    Life Sciences.2015; 124: 8.     CrossRef
  • Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
    Jung Won Lee, Jong Pil Im, Jae Hee Cheon, You Sun Kim, Joo Sung Kim, Dong Soo Han
    Intestinal Research.2015; 13(3): 213.     CrossRef
  • Effect of Ixeris dentata Nakai Extract on Nitric Oxide Production and Prostaglandin E2 Generation in LPS-stimulated RAW264.7 Cells
    Yu Yeon Jung, Jin Tae Hong, Sang Bae Han, Young Hyun Park, Dong Ju Son
    Immune Network.2015; 15(6): 325.     CrossRef
  • CPT-11 activates NLRP3 inflammasome through JNK and NF-κB signalings
    Qian Li, Xiong Zhang, Weicheng Wang, LeLe Li, Qiang Xu, Xudong Wu, Yanhong Gu
    Toxicology and Applied Pharmacology.2015; 289(2): 133.     CrossRef
  • The Joint Effects of Lifestyle Factors and Comorbidities on the Risk of Colorectal Cancer: A Large Chinese Retrospective Case-Control Study
    Junjie Hang, Binxin Cai, Peng Xue, Lei Wang, Hai Hu, Yangyang Zhou, Shujuan Ren, Jiajin Wu, Meiying Zhu, Donghui Chen, Haiyan Yang, Liwei Wang, Nathan A. Ellis
    PLOS ONE.2015; 10(12): e0143696.     CrossRef
  • Overview of gastrointestinal cancer prevention in Asia
    Jong-Min Park, Ho-Jae Lee, Jun Hwan Yoo, Weon Jin Ko, Joo Young Cho, Ki Baik Hahm
    Best Practice & Research Clinical Gastroenterology.2015; 29(6): 855.     CrossRef
  • 12,500 View
  • 73 Download
  • 41 Web of Science
  • 40 Crossref
Close layer
Original Articles
Expression of Heat Shock Proteins and Cytokines in Response to Ethanol Induced Damage in the Small Intestine of ICR Mice
Sung Won Lee, Dong Wook Choi, Sung Chul Park, Hee Jung Kim, Yang Hoon Nam, Dae Hee Choi, Chang Don Kang, Sung Joon Lee, Wan Joo Chun, Young-Joon Ryu
Intest Res 2014;12(3):205-213.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.205
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Ethanol administration causes intestinal epithelial cell damage by increasing intestinal permeability and the translocation of endotoxins from intestinal bacterial flora. Heat shock proteins (HSPs) are associated with recovery and protection from cell damage. The aim of the current study was to investigate differences in the expression of HSPs in the small intestine and the biochemical changes attributable to ethanol-induced intestinal damage.

Methods

Ethanol (20%) was injected intraperitoneally (2.75 g/kg, 5.5 g/kg, 8.25 g/kg) in ICR mice and the same volume of saline was administered to controls. After 1 hour, the proximal, middle, and distal segments were taken from the small intestine and the degree of damage was analyzed. In each segment, the expression of HSPs was analyzed by western blotting. The expression of inflammatory mediators including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), cyclooxygenase-2 (COX-2), and antioxidant enzyme such as glutathione-S-transferase were compared using real-time polymerase chain reaction assays.

Results

In the control group, HSP70 increased in all segments of small intestine. Additionally, increases in the expression of HSP40 and HSP90 in the distal regions and an increase in HSP32 in the middle regions were observed. After ethanol treatment, greater histological damage was observed in the distal small intestine and significant decreases in HSPs were observed generally. Increased expression of IL-1β, TNF-α, and COX-2 was observed in small intestinal tissues exposed to ethanol-induced damage. However, there was no significant difference in the expression of an antioxidant enzyme.

Conclusions

Significant differences in the expression of HSPs in different intestinal regions were observed. These differences may have been attributable to the distribution of intestinal bacteria.

Citations

Citations to this article as recorded by  
  • Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review
    Konrad Sosnowski, Adam Przybyłkowski
    Gut Microbes.2024;[Epub]     CrossRef
  • The Influence of Alcohol Consumption on Intestinal Nutrient Absorption: A Comprehensive Review
    Molly Butts, Vijaya Lakshmi Sundaram, Usha Murughiyan, Alip Borthakur, Soudamani Singh
    Nutrients.2023; 15(7): 1571.     CrossRef
  • Gut epithelial inducible heat-shock proteins and their modulation by diet and the microbiota
    Marie-Edith Arnal, Jean-Paul Lallès
    Nutrition Reviews.2016; 74(3): 181.     CrossRef
  • Protéines du choc thermique inductibles dans l’épithélium intestinal : propriétés protectrices et modulation par le microbiote et des facteurs alimentaires
    Marie-Édith Arnal, Jean-Paul Lallès
    Cahiers de Nutrition et de Diététique.2016; 51(4): 186.     CrossRef
  • Preinduction of heat shock protein 70 protects mice against post-infection irritable bowel syndrome via NF-κB and NOS/NO signaling pathways
    Xuchun Zhou, Liwei Dong, Bo Yang, Zhoutao He, Yiyao Chen, Taozhi Deng, Baili Huang, Cheng Lan
    Amino Acids.2015; 47(12): 2635.     CrossRef
  • 4,575 View
  • 37 Download
  • 6 Web of Science
  • 5 Crossref
Close layer
The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
Hyun Il Seo, Dong Il Park, Tae Oh Kim, You Sun Kim, Suck-Ho Lee, Ji Won Kim, Jae Hak Kim, Jeong Eun Shin
Intest Res 2014;12(3):214-220.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.214
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Infliximab was introduced recently as a rescue therapy for ulcerative colitis (UC) patients refractory to conventional treatments such as therapy with 5-amiono salicylic acids (5-ASA), immune modulators, and corticosteroids. However, there is insufficient data about its efficacy and safety in Korea.

Methods

From 7 tertiary referral hospitals, 33 patients who were treated with infliximab for moderate to severe (Mayo score 6-12) UC refractory to conventional treatment were recruited to this study. Clinical remission was defined as a total Mayo score of 2 or lower and every subscore less than 2. Partial response was defined as a decrease of Mayo score at least 3 points from baseline.

Results

Twenty-three patients (69.7%) showed clinical remission and 29 patients (87.8%) showed partial response in the observation period. When the remission and non-remission groups were compared in univariate analysis, only a higher total Mayo score at base line (11.0±0.9 vs. 9.9±1.5; P=0.04) was related to remission. The remission maintenance rate decreased with time in the Kaplan-Meier analysis. Two patients experienced re-remission after the first remission followed by aggravation during infliximab treatment. Three patients stopped infliximab treatment owing to adverse events including rhabdomyolysis, pneumonia, and fever of unknown origin.

Conclusions

If there is no choice except surgery for UC patients refractory to conventional treatment, infliximab is an effective and relatively safe treatment option for these patients in Korea.

Citations

Citations to this article as recorded by  
  • Efficacy of Anti-TNF Therapy for the Treatment of Patients with Moderate-to-Severe Inflammatory Bowel Disease; a First Iranian Report
    Samaneh Mohagheghi Darehranj, Sudabeh Alatab, Homayoon Vahedi, Anahita Sadeghi, Alireza Sima, Masoud Malekzadeh, Amir Anoshiravani, Hafez Fakheri, Nasser Ebrahimi Daryani, Abdolhamid Mousavi, Fariborz Mansour-Ghanaei, Mohammad Javad Zahedi, Reza Malekzade
    Middle East Journal of Digestive Diseases.2019; 12(1): 12.     CrossRef
  • Novel treatments for inflammatory bowel disease
    Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
    The Korean Journal of Internal Medicine.2018; 33(1): 20.     CrossRef
  • Long-term outcomes of infliximab treatment and predictors of response in 195 patients with ulcerative colitis: a hospital-based cohort study from Korea
    Hyungil Seo, Kiju Chang, Sun-Ho Lee, Eun-Mi Song, Gwang-Un Kim, Myeongsook Seo, Ho-Su Lee, Sung-Wook Hwang, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
    Scandinavian Journal of Gastroenterology.2017; 52(8): 857.     CrossRef
  • Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin
    Kymberley Thorne, Laith Alrubaiy, Ashley Akbari, David G. Samuel, Sian Morrison-Rees, Stephen E. Roberts
    European Journal of Gastroenterology & Hepatology.2016; 28(4): 369.     CrossRef
  • Efficacy and safety of CT‐P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study
    Yoon Suk Jung, Dong Il Park, Young Ho Kim, Ji Hyun Lee, Pyoung Ju Seo, Jae Hee Cheon, Hyoun Woo Kang, Ji Won Kim
    Journal of Gastroenterology and Hepatology.2015; 30(12): 1705.     CrossRef
  • Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
    Jung Won Lee, Jong Pil Im, Jae Hee Cheon, You Sun Kim, Joo Sung Kim, Dong Soo Han
    Intestinal Research.2015; 13(3): 213.     CrossRef
  • Circulating Ghrelin Levels and Obestatin/Ghrelin Ratio as a Marker of Activity in Ulcerative Colitis
    Ja Young Jung, Ji Bong Jeong, Ji Won Kim, Su Hwan Kim, Seong-Joon Koh, Byeong Gwan Kim, Kook Lae Lee
    Intestinal Research.2015; 13(1): 68.     CrossRef
  • How to Write Bibliographies for Citing Domestic Academic Resources
    Hyun Jung Yi
    The Korean Journal of Gastroenterology.2015; 65(1): 70.     CrossRef
  • Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?
    Chang Soo Eun, Dong Soo Han
    Gut and Liver.2015;[Epub]     CrossRef
  • Current and Emerging Biologics for Ulcerative Colitis
    Sung Chul Park, Yoon Tae Jeen
    Gut and Liver.2015; 9(1): 18.     CrossRef
  • 4,855 View
  • 36 Download
  • 8 Web of Science
  • 10 Crossref
Close layer
Is Colonoscopy Necessary after Computed Tomography Diagnosis of Acute Diverticulitis?
Min Jung Kim, Young Sik Woo, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Poong-Lyul Rhee, Jae J. Kim, Soon Jin Lee, Young-Ho Kim
Intest Res 2014;12(3):221-228.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.221
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

A diagnosis of acute diverticulitis is based on computed tomography (CT). Colonoscopy is commonly performed after the acute event to exclude other diagnoses. This study aimed to determine whether colonoscopy is necessary and what additional information is gained from a colonoscopy after acute diverticulitis.

Methods

Acute diverticulitis was diagnosed by clinical criteria and characteristic CT findings. We analyzed the number of patients in whom colorectal cancers were diagnosed and other incidental findings of polyps and other diseases.

Results

A total of 177 patients were analyzed retrospectively. The mean age was 43.3±15.3 years (range, 13-82 years) and 97 patients (54.8%) were male. Sixty-one patients had undergone a colonoscopy within 1 year of the acute attack. Advanced adenomatous lesions and colonic malignancy were not detected. Nineteen patients (31.1%) had ≥1 polyp and 11 patients (18.0%) had an adenomatous polyp. No new or different diagnosis was made after colonoscopy. None of the 116 patients who did not undergo colonoscopy within a year after acute diverticulitis had a diagnosis of colorectal cancer registered with the Korea Central Cancer Registry.

Conclusions

Routine colonoscopy yields little benefit in patients with acute diverticulitis diagnosed by typical clinical symptoms and CT. The current practice of a colonoscopy after acute diverticulitis needs to be reevaluated.

Citations

Citations to this article as recorded by  
  • Endoscopic findings after CT proven acute diverticulitis: a systematic review and meta‐analysis
    Amy Millicent Yesheng Cao, Vincent Wai Lam, Matthew John Francis Xavier Rickard
    ANZ Journal of Surgery.2023; 93(5): 1150.     CrossRef
  • Infection or Inflammation: Are Uncomplicated Acute Appendicitis, Acute Cholecystitis, and Acute Diverticulitis Infectious Diseases?
    Philip S. Barie, Lillian S. Kao, Mikayla Moody, Robert G. Sawyer
    Surgical Infections.2023; 24(2): 99.     CrossRef
  • Risk for colorectal cancer after computed tomography verified acute diverticulitis: A retrospective cohort study with long-term follow-up
    Leena-Mari Mäntymäki, Juha Grönroos, Markus Riskumäki, Tero Vahlberg, Jukka Karvonen
    Scandinavian Journal of Surgery.2023; 112(3): 157.     CrossRef
  • Diagnosis and management of acute colonic diverticulitis: results of a survey among Korean gastroenterologists
    Jae Gon Lee, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Shin Hee Lee, Myung-Won You, Seong-Eun Kim
    The Korean Journal of Internal Medicine.2023; 38(5): 672.     CrossRef
  • Comparative outcomes of acute colonic diverticulitis in immunocompromised versus immunocompetent patients: a systematic review and meta-analysis
    Jae Gon Lee, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Shin Hee Lee, Myung-Won You, Seong-Eun Kim
    Intestinal Research.2023; 21(4): 481.     CrossRef
  • Diagnosis and Treatment of Colonic Diverticular Disease
    You Sun Kim
    The Korean Journal of Gastroenterology.2022; 79(6): 233.     CrossRef
  • Diverticulitis does not increase the long-term risk of developing colon cancer: a systematic review and meta-analysis
    Laura Quitzau Mortensen, Jens Buciek, Kristoffer Andresen, Jacob Rosenberg
    International Journal of Colorectal Disease.2022; 37(9): 1945.     CrossRef
  • Acute complicated diverticulitis is associated with an increased advanced neoplasia diagnosis rate
    Fadi Abu Baker, Mohanad Ganayem, Amir Mari, Randa Taher, Mohamad Suki, Yael Kopelman
    Medicine.2021; 100(5): e24271.     CrossRef
  • Systematic Review and Meta-analysis on Colorectal Cancer Findings on Colonic Evaluation After CT-Confirmed Acute Diverticulitis
    Chee Hoe Koo, Jasmine H.E. Chang, Nicholas L. Syn, Ian J.Y. Wee, Ronnie Mathew
    Diseases of the Colon & Rectum.2020; 63(5): 701.     CrossRef
  • Risk of Colorectal Cancer in Patients With Acute Diverticulitis: A Systematic Review and Meta-analysis of Observational Studies
    Jeremy Meyer, Lorenzo A. Orci, Christophe Combescure, Alexandre Balaphas, Philippe Morel, Nicolas C. Buchs, Frédéric Ris
    Clinical Gastroenterology and Hepatology.2019; 17(8): 1448.     CrossRef
  • What radiologists should know about tomographic evaluation of acute diverticulitis of the colon
    Aline de Araújo Naves, Giuseppe D'Ippolito, Luis Ronan Marquez Ferreira Souza, Sílvia Portela Borges, Glênio Moraes Fernandes
    Radiologia Brasileira.2017; 50(2): 126.     CrossRef
  • High Probability of an Underlying Colorectal Cancer Among Patients Treated for Acute Diverticulitis. A Population‐Based Cohort Follow‐Up Study
    Carl Johan Grahnat, Sebastian Hérard, Annicka Ackzell, Roland E. Andersson
    World Journal of Surgery.2016; 40(9): 2283.     CrossRef
  • Colonoscopy after Hinchey I and II left-sided diverticulitis: utility or futility?
    Avery S. Walker, Jason R. Bingham, Karmon M. Janssen, Eric K. Johnson, Justin A. Maykel, Omar Ocampo, John P. Gonzalez, Scott R. Steele
    The American Journal of Surgery.2016; 212(5): 837.     CrossRef
  • 14,673 View
  • 88 Download
  • 15 Web of Science
  • 13 Crossref
Close layer
Prediction of Tumor Recurrence in Patients with Non-Gastric Gastrointestinal Stromal Tumors Following Resection according to the Modified National Institutes of Health Criteria
Seung Hyeon Jang, Ji Eun Kwon, Jee Hyun Kim, June Young Lee, Sang Gyun Kim, Joo Sung Kim, Hyun Chae Jung, Jong Pil Im
Intest Res 2014;12(3):229-235.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.229
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Few studies have investigated the prognosis of non-gastric gastrointestinal stromal tumors (GISTs) under the modified National Institutes of Health (NIH) consensus criteria in Korea. This study aims to clarify the clinical usefulness of the modified NIH criteria for risk stratification.

Methods

From January 2000 through October 2012, 88 patients who underwent curative resection for primary GISTs were included in this study. The enrolled patients were stratified to predict recurrence by the original NIH criteria and modified NIH criteria.

Results

In all, 88 patients had non-gastric GISTs, including 82 and 6 patients with GISTs of the small intestine and colorectum, respectively. The mean age was 57.3±13.0 years, and the median follow-up duration was 3.40 years (range, 0.02-12.76 years). All patients who were placed in the intermediate-risk category according to the original NIH criteria were reclassified into the high-risk category according to the modified NIH criteria. Therefore, the proportion of cases in the intermediate-risk category declined to 0.0% from 25.0% (22/88), and the proportion of cases in the high-risk category increased to 43.2% (38/88) from 18.2% (16/88) under the modified NIH criteria. Among the 22 reclassified patients, 6 (27.3%) suffered a recurrence during the observational period, and the recurrence rate of high-risk category patients was 36.8% (14/38).

Conclusions

Patients in the high-risk category according to the modified NIH criteria had a high GIST recurrence rate. Therefore, the modified NIH criteria are clinically useful in selecting patients who need imatinib adjuvant chemotherapy after curative surgical resection.

Citations

Citations to this article as recorded by  
  • Radiologic Review of Small Bowel Malignancies and Their Mimicking Lesions
    Jong Soo Lee, So Hyun Park, Seung Joon Choi
    Journal of the Korean Society of Radiology.2023; 84(1): 110.     CrossRef
  • Assessment of a Real-world Learning Curve for the Endoscopic Resection of Gastric Gastrointestinal Stromal Tumors
    Ying Sun, Luojie Liu, Dongtao Shi, Chao Ma, Xiaodan Xu
    Journal of International Medical Research.2023;[Epub]     CrossRef
  • Gastrointestinal Stromal Tumors of the Stomach and Esophagus
    Lauren Theiss, Carlo M. Contreras
    Surgical Clinics of North America.2019; 99(3): 543.     CrossRef
  • Comparison of Different Risk Classification Systems in 558 Patients with Gastrointestinal Stromal Tumors after R0-Resection
    Michael Schmieder, Doris Henne-Bruns, Benjamin Mayer, Uwe Knippschild, Claudia Rolke, Matthias Schwab, Klaus Kramer
    Frontiers in Pharmacology.2016;[Epub]     CrossRef
  • A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib
    Dong Kyung Chang
    Intestinal Research.2014; 12(3): 176.     CrossRef
  • 37,093 View
  • 54 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
A Double-Blind, Randomized, Active Drug Comparative, Parallel-Group, Multi-Center Clinical Study to Evaluate the Safety and Efficacy of Probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in Patients with Diarrhea
Jun Heo, Sung Kook Kim, Kyung Sik Park, Hye Kyung Jung, Joong Goo Kwon, Byung Ik Jang
Intest Res 2014;12(3):236-244.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.236
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Bacillus Licheniformis, a probiotic used in the treatment of diarrhea, has been shown to suppress the growth of pathologic bacteria. This study was performed to assess the therapeutic efficacy and safety of Zhengchangsheng® (Bacillus Licheniformis) in comparison with another probiotic, Bioflor® (Saccharomyces Boulardii) for the treatment of diarrhea.

Methods

Patients with diarrhea (n=158) were randomized to receive Zhengchangsheng® or Bioflor® for 5 days. The existence or non-existence of formed feces, changes in daily stool frequency, improvement of subjective symptoms, and changes in the severity of diarrhea were compared.

Results

Of the 158 full analysis set (FAS) patient population, 151 patients comprised the per protocol (PP) analysis. The rates of recovered to formed feces in the Bacillus and Saccharomyces groups were 91.0% vs. 95.0% in the FAS (P=0.326) and 90.5% vs. 96.1% in the PP analysis (P=0.169), respectively. The mean duration of diarrhea changing to formed feces was 3.15±1.10 days in the Bacillus group and 3.22±1.01 in the Saccharomyces group (P=0.695, FAS). The frequency of defecation, subjective symptoms, and degree of severe diarrhea were improved in both groups, however, there were no statistically significant differences between the 2 groups. Analysis of the 95% confidence intervals for the differences in the rate of recovery to formed feces between the 2 groups met the criteria for non-inferiority of Bacillus compared to Saccharomyces. No significant adverse events were observed during the study period.

Conclusions

Zhengchangsheng® is not inferior to Bioflor® in therapeutic efficacy and is a safe and useful therapeutic agent for the treatment of diarrhea.

Citations

Citations to this article as recorded by  
  • Common protein networks for various drug regimens of major depression are associated with complement and immunity
    Seungyeon Lee, Sora Mun, Jiyeong Lee, Hee-Gyoo Kang
    Journal of Psychopharmacology.2024;[Epub]     CrossRef
  • Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial
    Qian Zhou, Wenkui Dai, Yanmin Bao, Jing Chen, Xiaohua Han, Changshan Liu, Meijie Hou, Huisheng Yao, Changsuo Hao, Shuaicheng Li, Yuejie Zheng
    Clinical and Translational Medicine.2023;[Epub]     CrossRef
  • Weizmannia coagulans: an Ideal Probiotic for Gut Health
    Shiqi Zhang, Pinglan Li, Suwon Lee, Yu Wang, Chunming Tan, Nan Shang
    Food Science and Human Wellness.2023; : 1.     CrossRef
  • Bacillus licheniformis prevents and reduces anxiety-like and depression-like behaviours
    Siyuan Feng, Chen Meng, Yiyuan Liu, Yue Yi, Axin Liang, Yingyu Zhang, Zikai Hao
    Applied Microbiology and Biotechnology.2023; 107(13): 4355.     CrossRef
  • Bacteremia caused by accidental injection of Bacillus licheniformis microbiota modulator through the central venous catheter
    Chuan Zhong, Fen Wang, Haining Zhou, Jiarui Liu, Jiewei Hu, Yongjun Chen
    Medicine.2022; 101(4): e28719.     CrossRef
  • Bacillus licheniformis Reshapes the Gut Microbiota to Alleviate the Subhealth
    Siyuan Feng, Chen Meng, Zikai Hao, Hong Liu
    Nutrients.2022; 14(8): 1642.     CrossRef
  • The effect of multispecies probiotics on cognitive reactivity to sad mood in patients with Crohn’s disease
    Lipei Wu, Fujun Shen, Weiwei Wang, Chunrun Qi, Chunbin Wang, Anquan Shang, Shihai Xuan
    Journal of Functional Foods.2021; 82: 104431.     CrossRef
  • Bacillus licheniformis Zhengchangsheng® Inhibits Obesity by Regulating the AMP-Activated Protein Kinase Signaling Pathway
    Xiaojie Lu, Yue Jing, Xiaofei Zhou, Naisheng Zhang, Jiandong Tai, Yongguo Cao
    Probiotics and Antimicrobial Proteins.2021; 13(6): 1658.     CrossRef
  • Oral Supplements of Combined Bacillus licheniformis Zhengchangsheng® and Xylooligosaccharides Improve High-Fat Diet-Induced Obesity and Modulate the Gut Microbiota in Rats
    Yuyuan Li, Man Liu, He Liu, Xiaoqing Wei, Xianying Su, Ming Li, Jieli Yuan
    BioMed Research International.2020; 2020: 1.     CrossRef
  • Bacillus licheniformis Zhengchangsheng® attenuates DSS-induced colitis and modulates the gut microbiota in mice
    Y. Li, M. Liu, J. Zhou, B. Hou, X. Su, Z. Liu, J. Yuan, M. Li
    Beneficial Microbes.2019; 10(5): 543.     CrossRef
  • Broad Prebiotic Potential of Non-starch Polysaccharides from Oats (Avena sativa L.): an in vitro Study
    VANDA SARGAUTIENE, ILVA NAKURTE, VIZMA NIKOLAJEVA
    Polish Journal of Microbiology.2018; 67(3): 307.     CrossRef
  • Effect of Bacillus subtilis C-3102 on loose stools in healthy volunteers
    M. Hatanaka, K. Yamamoto, N. Suzuki, S. Iio, T. Takara, H. Morita, T. Takimoto, T. Nakamura
    Beneficial Microbes.2018; 9(3): 357.     CrossRef
  • Rapid and simple detection of endospore counts in probiotic Bacillus cultures using dipicolinic acid (DPA) as a marker
    Xiao-Sheng Liang, Chun Liu, Zhu Long, Xiao-Hua Guo
    AMB Express.2018;[Epub]     CrossRef
  • Gut Microbiota in Health and Probiotics in Functional Bowel Disease
    Jai Hyun Rhyou
    The Ewha Medical Journal.2017; 40(1): 22.     CrossRef
  • Separation and determination of peptide metabolite of Bacillus licheniformis in a microbial fuel cell by high-speed capillary micellar electrokinetic chromatography
    Wei Wang, Ruiguang Bai, Xiaoyu Cai, Ping Lin, Lihong Ma
    Journal of Separation Science.2017; 40(22): 4446.     CrossRef
  • Evaluation of chitosan hydrochloride-alginate as enteric micro-probiotic-carrier with dual protective barriers
    Qing-Xi Wu, Xin Xu, Qiu Xie, Wang-Yu Tong, Yan Chen
    International Journal of Biological Macromolecules.2016; 93: 665.     CrossRef
  • 9,483 View
  • 70 Download
  • 17 Web of Science
  • 16 Crossref
Close layer
Case Reports
A Case of Localized Amyloid Light-Chain Amyloidosis in the Small Intestine
Jong Hyo Choi, Bong Min Ko, Cheol Kim, Hee Kyung Kim, Jae Pil Han, Su Jin Hong, Jong Ho Moon, Moon Sung Lee
Intest Res 2014;12(3):245-250.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.245
AbstractAbstract PDFPubReaderePub

Amyloidosis is characterized by the abnormal deposition of extracellular amyloid fibrils. Cases involving amyloid light-chain amyloidosis in the small intestine have been reported infrequently in Korea. Here, we report a case of localized light chain protein amyloidosis in the small intestine. Esophagogastroduodenoscopy, push enteroscopy, and capsule endoscopy revealed submucosal tumor-like lesions, multiple shallow ulcers, and several erosions in the distal duodenum and jejunum. An endoscopic biopsy established the diagnosis of amyloidosis. In through an immunohistochemical analysis, the presence of lambda light chain protein was detected. The patient had no evidence of an underlying clonal plasma cell disorder or additional organ involvement. Therefore, we concluded that the patient had localized amyloidosis of the small intestine.

Citations

Citations to this article as recorded by  
  • A systematic review of the literature on localized gastrointestinal tract amyloidosis: Presentation, management and outcomes
    Mariuxi Alexandra Viteri Malone, David Alfonso Alejos Castillo, Heitor Tavares Santos, Anahat Kaur, Tarek Elrafei, Lewis Steinberg, Abhishek Kumar
    European Journal of Haematology.2024; 113(4): 400.     CrossRef
  • Systemic Immunoglobulin Light Chain Amyloidosis Involving the Large Intestine
    Renugadevi Swaminathan, Samuel Igbinedion, Sudha Pandit
    ACG Case Reports Journal.2021; 8(5): e00578.     CrossRef
  • Unusual case of amyloidosis presenting as a jejunal mass
    Sachin Mohan, Elliot Graziano, James Campbell, Irshad H Jafri
    BMJ Case Reports.2021; 14(5): e240226.     CrossRef
  • Gastrointestinal AA amyloidosis secondary to chronic pyelonephritis presenting with refractory diarrhea and severe hypoalbuminemia
    Tomoko Tanaka, Tatsushi Naito, Yohei Midori, Takuto Nosaka, Kazuto Takahashi, Kazuya Ofuji, Hidetaka Matsuda, Masahiro Ohtani, Katsushi Hiramatsu, Yoshiaki Imamura, Osamu Yokoyama, Hironobu Naiki, Yasunari Nakamoto
    Clinical Journal of Gastroenterology.2021; 14(6): 1642.     CrossRef
  • Morphological and Immunohistochemical Characteristics of Experimental Mandibular Fractures Healing Process
    A. A. Matchin, A. A. Stadnikov, E. V. Nosov, S. Kh. Kiriakidi
    Journal of Anatomy and Histopathology.2019; 8(1): 44.     CrossRef
  • Specific Clinical and Morphological Characteristics of Amyloidosis of the Stomach and Duodenum
    Z. V. Gioeva, L. M. Mikhaleva
    Journal of Anatomy and Histopathology.2019; 8(1): 39.     CrossRef
  • Localized Gastrointestinal ALλ Amyloidosis
    Tomoya Iida, Kentaro Yamashita, Hiroshi Nakase
    Clinical Gastroenterology and Hepatology.2018; 16(9): e93.     CrossRef
  • Small Bowel Amyloidosis
    Raghav Bansal, Umer Syed, Jacob Walfish, Joshua Aron, Aaron Walfish
    Current Gastroenterology Reports.2018;[Epub]     CrossRef
  • Systemic amyloidosis with gastrointestinal involvement: Diagnosis from endoscopic and histological views
    Tomoya Iida, Hiroo Yamano, Hiroshi Nakase
    Journal of Gastroenterology and Hepatology.2018; 33(3): 583.     CrossRef
  • 10,016 View
  • 67 Download
  • 6 Web of Science
  • 9 Crossref
Close layer
Two Cases of Gastrocolocutaneous Fistula with a Long Asymptomatic Period after Percutaneous Endoscopic Gastrostomy
Hyo Sun Kim, Chang Seok Bang, Yeon Soo Kim, Oh Kyung Kwon, Min Sun Park, Jeong Ho Eom, Gwang Ho Baik, Dong Joon Kim
Intest Res 2014;12(3):251-255.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.251
AbstractAbstract PDFPubReaderePub

Gastrocolocutaneous fistula is a rare complication of the percutaneous endoscopic gastrostomy (PEG) procedure. Typical symptoms usually occur in the first few months. We recently encountered 2 patients with 8- and 33-month asymptomatic periods. A 74-year-old man presented with watery diarrhea for 1 month. He had undergone PEG 9 months earlier. During workup, an upper endoscopy and abdominal CT scan revealed the migration of the feeding tube into the transverse colon. He was discharged with a nasogastric tube after treatment. A 77-year-old man presented with sudden loosening of his PEG tube with a duration over 3 days. He had undergone PEG procedure three times until that time. During workup, a gastrocolocutaneous fistula was diagnosed. However, when previous studies were reviewed, an abdominal CT scan, which was done 6 months ago before the third PEG, showed the fistula already existed at that time, suggesting that it was created about 33 months earlier when he underwent the second PEG procedure. The patient died of pneumonia aggravation despite conservative treatment. Both a high index of suspicion and the careful inspection of the upper endoscopy are very important for early diagnosis regardless of symptoms.

Citations

Citations to this article as recorded by  
  • How far is the endoscopist to blame for a percutaneous endoscopic gastrostomy complication?
    George Stavrou, Persefoni Gionga, George Chatziantoniou, Georgios Tzikos, Alexandra Menni, Stavros Panidis, Anne Shrewsbury, Katerina Kotzampassi
    World Journal of Gastrointestinal Surgery.2023; 15(5): 940.     CrossRef
  • General principles for the prevention and treatment of complications of percutaneous endoscopic gastrostomy (review of literature)
    K. V. Golubev, E. E. Topuzov, V. V. Oleynik, T. R. Stuchevskaya, S. V. Gorchakov
    The Scientific Notes of the Pavlov University.2020; 26(3): 25.     CrossRef
  • Complex gastro-colo-cutaneous fistula secondary to a gunshot injury, management and literature review
    Maha Al Shaibi, Mohamed Al Abri, Ghaitha Al Mahruqi, Alok Mittal
    Trauma Case Reports.2020; 28: 100313.     CrossRef
  • Long-Term Gastrocolocutaneous Fistula after Endoscopic Gastrostomy: How Concerned Should We Be?
    Gonçalo Nunes, Gabriel Paiva de Oliveira, João Cruz, Carla Adriana Santos, Jorge Fonseca
    GE - Portuguese Journal of Gastroenterology.2019; 26(6): 441.     CrossRef
  • Gastrocolocutaneous Fistula: An Unusual Case of Gastrostomy Tube Malfunction with Diarrhea
    Junghwan Lee, Jinyoung Kim, Ha il Kim, Chung Ryul Oh, Sungim Choi, Soomin Noh, Hee Kyong Na, Hwoon-Yong Jung
    Clinical Endoscopy.2018; 51(2): 196.     CrossRef
  • Successful treatment of an iatrogenic gastro-colo-cutaneous fistula in a patient with Chilaiditi syndrome: A case report
    Shutaro Gunji, Hokahiro Katayama, Shigehiro Morikawa, Aaron Tan
    Cogent Medicine.2017; 4(1): 1331600.     CrossRef
  • Gastro-Hepatic Fistula with Liver Abscess: A Rare Complication of a Common Procedure
    Arsalan Rafiq, Naeem Abbas, Hassan Tariq, Suresh Kumar Nayudu
    American Journal of Case Reports.2015; 16: 652.     CrossRef
  • 6,638 View
  • 44 Download
  • 4 Web of Science
  • 7 Crossref
Close layer
Images of the Issue
A Patient with Hematochezia and Intestinal Obstruction
Kyong Yong Oh, Yoon Jae Kim
Intest Res 2014;12(3):256-257.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.256
PDFPubReaderePub
  • 3,825 View
  • 24 Download
Close layer
Letterses to the Editor
Endoscopic Postoperative Recurrence Rates in Crohn's Disease in Korea: The Beginning of a New Approach?
Paulo Gustavo Kotze, Rogerio Saad-Hossne, Antonino Spinelli
Intest Res 2014;12(3):258-259.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.258
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
    Sakiko Hiraoka, Shiho Takashima, Yoshitaka Kondo, Toshihiro Inokuchi, Yuusaku Sugihara, Masahiro Takahara, Seiji Kawano, Keita Harada, Jun Kato, Hiroyuki Okada
    Intestinal Research.2018; 16(1): 75.     CrossRef
  • Author's Reply
    Kang-Moon Lee
    Intestinal Research.2014; 12(3): 260.     CrossRef
  • 8,749 View
  • 28 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
Author's Reply
Kang-Moon Lee
Intest Res 2014;12(3):260-261.   Published online July 25, 2014
DOI: https://doi.org/10.5217/ir.2014.12.3.260
PDFPubReaderePub
  • 4,052 View
  • 20 Download
Close layer

Intest Res : Intestinal Research
Close layer
TOP